Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

27.28 +0.32 (+1.19%)
Official Closing Price Updated: 6:30 PM EDT, Mar 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
The Grand Divergence: Finance Surges as Health Care Braces for a Historic Q1 Earnings Slump
As the first quarter of 2026 draws to a close, the S&P 500 is witnessing one of the most dramatic sector performance splits in recent financial history. According to consensus estimates as of March 17,... 
Via MarketMinute
Topics Earnings Economy Initial Public Offering
News headline image
Pfizer Touts Promising Survival Data Without Worsening For Advanced Breast Cancer Patients ↗
Pfizer trial results for a new breast cancer treatment showed improved progression-free survival and a manageable safety profile. 
Via Benzinga
News headline image
Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer
From Pfizer Inc.
Via Business Wire
News headline image
Should You Avoid Pfizer? Here's the Key Risk to Watch ↗
Pfizer has reached a turning point. 
Via The Motley Fool
Topics Intellectual Property
News headline image
1 Cash-Producing Stock to Target This Week and 2 That Underwhelm
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
The mRNA Renaissance: Moderna’s 83% Surge Leads the 2026 Healthcare Recovery
The biotech sector has found its new North Star in 2026. As of mid-March, Moderna Inc. (NASDAQ: MRNA) has shocked Wall Street with a staggering 83% year-to-date gain, catapulting it to the upper... 
Via MarketMinute
Topics Artificial Intelligence Initial Public Offering Stocks
News headline image
VCIT Offers Broader Diversification Than FIGB ↗
Explore how differences in cost, risk, and portfolio breadth could impact your choice between these two bond ETFs. 
Via The Motley Fool
Topics Bonds ETFs
News headline image
Rushing Headlong: Health IT's Legacy and the Road to Responsible AI Named 2025 Foreword INDIES Book of the Year Awards Finalist
Via PRLog
Topics Artificial Intelligence
News headline image
Merck & Co. Trades Ex-Dividend as Healthcare Emerges as a Volatility Hedge in 2026
Amidst a backdrop of mounting geopolitical tensions and sharp swings in the broader indices, pharmaceutical giant Merck & Co. (NYSE: MRK) officially trades ex-dividend today, March 16, 2026. Investors... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
3 Monster Dividend Stocks to Hold for the Next 10 Years ↗
These dividend stocks are built for the long haul. 
Via The Motley Fool
Topics Artificial Intelligence Energy
News headline image
The Stock Market May Be Shifting From Risky Tech Stocks to Safer Sectors. Here Are 3 Stocks to Buy Before They Soar. ↗
Plenty of companies do just fine regardless of the economic environment. 
Via The Motley Fool
Topics Artificial Intelligence Economy
Explore the S&P500 index on Friday and find out which stocks are the most active in today's session. ↗
Via Chartmill
News headline image
1 Magnificent Dividend Stock Down 57% to Buy and Hold Forever ↗
This healthcare giant is trading at a discounted price today. 
Via The Motley Fool
Topics Intellectual Property
News headline image
2 Healthcare Stocks with Solid Fundamentals and 1 Facing Challenges
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have se... 
Via StockStory
News headline image
Starboard Value Is Betting Big on This Blue-Chip Dividend Stock. Should You?
Starboard does not have a stellar recent record, and Lamb Weston is facing its own issues. Here's what investors need to know about Lamb Weston. 
Via Barchart.com
News headline image
Complementing the Future: A Deep Dive into Dianthus Therapeutics (DNTH) After Its Phase 3 Breakthrough
Date: March 12, 2026 Introduction Dianthus Therapeutics (NASDAQ: DNTH) has become the center of Wall Street’s attention today, with its share price surging 19.4% in early trading following a pivotal... 
Via Finterra
Topics Economy
News headline image
The Azetukalner Breakthrough: A Deep Dive into Xenon Pharmaceuticals (XENE)
Date: March 12, 2026Sector: Biotechnology / NeurologyMarket Cap: ~$4.8 Billion Introduction On March 9, 2026, the neurology sector of the biotechnology market witnessed a seismic shift. Xenon... 
Via Finterra
Topics ETFs Intellectual Property
News headline image
The Best Covered Call Strategy to Trade High-Yielding Pfizer Stock and Earn Extra Income
Income investors tend to gravitate towards covered calls, and blue-chip high yielding stocks are a great place to start. Pfizer (PFE) has been a strong performer in 2026 and is up 9.64% so far this... 
Via Barchart.com
Stay informed about the most active stocks in the S&P500 index on Wednesday's session. ↗
Via Chartmill
News headline image
Why BridgeBio Leapfrogged Its 50-Day Line On Pfizer's Patent Shake-Up ↗
Shares popped Tuesday on a notable shake-up in the patent battle surrounding Pfizer's rival drug, tafamidis. 
Via Investor's Business Daily
Topics Intellectual Property
News headline image
2 Healthcare Stocks That Are Too Cheap to Ignore ↗
These companies' shares have fallen too far, offering investors an attractive opportunity. 
Via The Motley Fool
News headline image
BioNTech Navigates Post-Pandemic Deficit: A €17 Billion Bet on the Oncology Frontier
In a watershed moment for the biotechnology sector, BioNTech SE (NASDAQ: BNTX) has reported its full-year 2025 financial results, signaling the definitive end of the COVID-19 vaccine gold rush and the... 
Via MarketMinute
News headline image
Pfizer (PFE) 2026 Research Feature: The High-Stakes Pivot to Oncology and Obesity
As of today, March 10, 2026, Pfizer Inc. (NYSE: PFE) stands at a pivotal crossroads in its 177-year history. After experiencing a meteoric rise during the COVID-19 pandemic followed by a sobering... 
Via Finterra
Topics Economy Intellectual Property Lawsuit
News headline image
The Potassium Channel Breakthrough: A Deep-Dive on Xenon Pharmaceuticals (XENE)
As of March 10, 2026, the biopharmaceutical sector is witnessing a historic realignment in the neurology space, spearheaded by the Canadian-born clinical powerhouse Xenon Pharmaceuticals Inc. (Nasdaq:... 
Via Finterra
Topics Economy Initial Public Offering Intellectual Property
News headline image
3 Healthcare Stocks Paying the Highest Dividends of 2026 ↗
A handful of the industry's income-generating gems are hiding in plain sight. 
Via The Motley Fool
News headline image
1 S&P 500 Stock with Promising Prospects and 2 We Avoid
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ... 
Via StockStory
Topics Stocks
Looking for the most active stocks in the S&P500 index on Monday? ↗
Via Chartmill
News headline image
Pfizer's Payout Ratio Is Still Over 100%. Is a Dividend Cut Inevitable? ↗
The company incurred a loss in its most recent quarterly results. 
Via The Motley Fool
Topics Intellectual Property
News headline image
2 Top AI Healthcare Stocks to Buy and Hold ↗
AI is a valuable tool that could unlock significant value for these healthcare leaders and their shareholders. 
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
News headline image
Pfizer’s Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis
From Pfizer Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.